Abstract:Cardiac troponin I(cTnI) was separated and purified from human left ventricular tissue by affinity chromatographic method and used to immunize Balb/c mice by intraperitoneal injection and four hybridoma cell lines. which secreted monoclonal antibody(mAb) against human cTnI, were obtained by cell fusion, identification and cloning twice. Three mAbs(9F5, 2F11, 8C12) were produced from the ascites of Balb/c mice injected intraperitoneally the hybridoma cells and characterized by means of a surface plasmon resonance(SPR) biosensor. An optimal and specific sensing membrane for troponin I was prepared with staphylococcal protein A(SPA) as the intermediate layer and mAb against human cTnI as the capture antibody. On the basis of the sensing membrane, two modes of operation of the SPR biosensor were developed, i.e.. a direct detection of antigen-antibody affinity and a sandwich assay. In the sandwich assay detection mode, the mAbs competition was measured by monitoring whether the secondary antibody had been attached to the cTnI already captured by the first antibody on the sensor surface. The SPR biosensor was shown to be able to directly detect the antigen-antibody affinity and the order of the affinity was found to be 9F5>2F11>8C12. In the sandwich detection mode. it was found that the different epitopes on the cTnI molecules were recognized by the three mAbs respectively, but the asymmetrical competition was shown between 2F11 and 8C12 and no competition was found between 9F5 and 2F11 or 8c12. Based on these results, a double monoclonal sandwich immunoassay for cTnI was developed by using the optimal antibody pair of 9F5 and 2F11 and the SPR biosensor with SPA substrate membrane, which showed an excellent sensitivity of 0.8 mug/L for both the buffer and the serum samples compared with the direct detection of cTnI for the buffer with the lowest detection limit of 4 mug/L and conventional ELISA with the sensitivity of 1.9 mug/L.

Establishment and Identification of Hybridoma Cell Lines Secreting Anti-human Myocardial Troponin T Antibody

[Development, Identification and Application of 33 Monoclonal Antibodies Against Cardiac Troponin T].

Preparation of anti-cardiac troponin I monoclonal antibodies and their characterization with surface plasmon resonance biosensor

Antigen Design in Production of Anti-Human Cardiac Troponin Ⅰ Monoclonal Antibody

Preparation of monoclonal antibodies against troponin I and development of one-step sandwich ELISA

Expression of cTnI Specific Antigen Sites and Antibodies Detection

Establishment of chemiluminescence enzyme immunoassay for detecting human cardiac troponin I

[Development of Hybridoma Cell Lines Secreting Monoclonal Antibodies Against ADAMTS13].

Cloning and Expression of Human Fetal Cardiac Troponin T Isoform

Establishment of Hybridoma Cell Lines Secreting High-titred Monoclonal Antibodies to Oxytocin

The Impact of Antibody Selection on the Detection of Cardiac Troponin I.

Purification and Identification of human Myocardial Troponin T

PREPARATION OF MONOCLONAL-ANTIBODIES AGAINST THYROID-STIMULATING HORMONE (TSH)

Preparation and Immunologic Characterization of a Monoclonal Antibody Against Human Trophoblast Cell-Surface Antigen 2

Isolation and Purification of Human Cardiac Troponin Ⅰ Using Affinity Chromatography

Preparation and Identification of Monoclonal Antibodies Against Humanin

[Preparation and Application of Monoclonal Antibody Against Human Myoglobin].

ESTABLISHMENT OF FOUR HYBRIDOMA CELL LINES SECRETING ANTI-HUMAN IGA MCABS

[Preparation, Purification and Characterization of the Polyclonal Antibody Against Human CMTM4].

Extraction and Purification of Human Cardiac Troponin I by Affinity Chromatography

Two Desired Epitopes of Ctni Benefit for Preparation of Standardized Monoclonal Antibodies.